Literature DB >> 21430541

Opioids for chronic pain: promise and pitfalls.

Catherine F Stannard1.   

Abstract

PURPOSE OF REVIEW: The prescribing of opioid medicines is increasing progressively despite a substantial body of literature identifying potential limitations and harms of therapy. Production and dissemination of best practice guidance in relation to prescribing do not yet seem to have an impact on this trend. This article highlights updated concerns about and unanswered questions in relation to opioid treatment to provide focus for further scrutiny and evaluation of opioid treatment for pain. RECENT
FINDINGS: The literature cited in this paper confirms that opioid prescribing is prevalent despite an established evidence base spanning a decade that indicates that efficacy of opioids in long-term pain management remains uncertain and that harms of therapy are well defined. In particular, problems with treatment are more likely to occur when high doses are used and in certain patient populations and many recent high-quality studies highlight these problems. Although much is to be learned regarding clinical decision making, it is clear that current prescribing activity does not reflect the existing knowledge base.
SUMMARY: Authors are unanimously agreed that the literature answers some important questions about opioid therapy but there are substantial knowledge gaps, particularly in relation to benefits and harms of long-term therapy in day-to-day clinical practice. Evidence-derived guidance clearly identifies common and important pitfalls in relation to opioid use but promotion of adherence to guidance remains a substantial challenge.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430541     DOI: 10.1097/SPC.0b013e3283458fbc

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  6 in total

1.  Deficits in neuronal cytochrome P450 activity attenuate opioid analgesia but not opioid side effects.

Authors:  Lindsay B Hough; Julia W Nalwalk; Rachel A Cleary; James G Phillips; Cheng Fang; Weizhu Yang; Xinxin Ding
Journal:  Eur J Pharmacol       Date:  2014-07-22       Impact factor: 4.432

2.  A fall from grace: exposing the neurotoxicities of morphine.

Authors:  Sam H Ahmedzai
Journal:  Br J Pain       Date:  2016-10-13

Review 3.  Using automated patch clamp electrophysiology platforms in pain-related ion channel research: insights from industry and academia.

Authors:  Damian C Bell; Mark L Dallas
Journal:  Br J Pharmacol       Date:  2017-07-18       Impact factor: 8.739

4.  Antinociceptive activity of CC44, a biotinylated improgan congener.

Authors:  Paul Hoerbelt; Julia W Nalwalk; James G Phillips; Mark P Wentland; Zhixing Shan; Lindsay B Hough
Journal:  Eur J Pharmacol       Date:  2013-07-05       Impact factor: 4.432

5.  Update on prescription extended-release opioids and appropriate patient selection.

Authors:  Michael J Brennan
Journal:  J Multidiscip Healthc       Date:  2013-07-23

6.  The Pain Divide: a cross-sectional analysis of chronic pain prevalence, pain intensity and opioid utilisation in England.

Authors:  Adam Todd; Nasima Akhter; Joanne-Marie Cairns; Adetayo Kasim; Nick Walton; Amanda Ellison; Paul Chazot; Sam Eldabe; Clare Bambra
Journal:  BMJ Open       Date:  2018-09-11       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.